# Ziconotide for Non-cancer Pain by Intrathecal Administration

> **NCT06541184** · — · RECRUITING · sponsor: **ESTEVE Pharmaceuticals SAS** · enrollment: 85 (estimated)

## Conditions studied

- Pain, Chronic

## Interventions

- **DRUG:** Ziconotide [Prialt]

## Key facts

- **NCT ID:** NCT06541184
- **Lead sponsor:** ESTEVE Pharmaceuticals SAS
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-30
- **Primary completion:** 2029-10-30
- **Final completion:** 2029-10-30
- **Target enrollment:** 85 (ESTIMATED)
- **Last updated:** 2025-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06541184

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06541184, "Ziconotide for Non-cancer Pain by Intrathecal Administration". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06541184. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*